Mark J. Ahn
2011
In 2011, Mark J. Ahn earned a total compensation of $1.1M as President and Chief Executive Officer at Galena Biopharma.
Compensation breakdown
| Bonus | $157,746 |
|---|---|
| Option Awards | $670,115 |
| Salary | $320,680 |
| Other | $225 |
| Total | $1,148,766 |
Ahn received $670.1K in option awards, accounting for 58% of the total pay in 2011.
Ahn also received $157.7K in bonus, $320.7K in salary and $225 in other compensation.
Rankings
In 2011, Mark J. Ahn's compensation ranked 5,161st out of 10,747 executives tracked by ExecPay. In other words, Ahn earned more than 52.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,161 out of 10,747 | 52nd |
Division Manufacturing | 1,869 out of 3,960 | 53rd |
Major group Chemicals And Allied Products | 400 out of 1,033 | 61st |
Industry group Drugs | 248 out of 781 | 68th |
Industry Pharmaceutical Preparations | 194 out of 571 | 66th |
Source: SEC filing on April 30, 2012.
Ahn's colleagues
We found five more compensation records of executives who worked with Mark J. Ahn at Galena Biopharma in 2011.
2011
Noah Beerman
Galena Biopharma
Chief Executive Officer
2011
Mark Schwartz
Galena Biopharma
Chief Operating Officer
2011
Anastasia Khvorova
Galena Biopharma
Chief Scientific Officer
2011
Pamela Pavco
Galena Biopharma
Vice President of Pharmaceutical Development, RXi Pharmaceuticals Corporation
2011
Kwang Lee
Galena Biopharma